NP421630.RAt9eHzD-LlUhvh5xt3-ebBqBVdHOXdccOcIppHJSNQF0
has assertion: NP421630.RAt9eHzD-LlUhvh5xt3-ebBqBVdHOXdccOcIppHJSNQF0130 assertion
has provenance: NP421630.RAt9eHzD-LlUhvh5xt3-ebBqBVdHOXdccOcIppHJSNQF0130 provenance
has publication info: NP421630.RAt9eHzD-LlUhvh5xt3-ebBqBVdHOXdccOcIppHJSNQF0130 publicationInfo
type: Nanopublication
created: 2016-05-13T12:44:56+02:00
rights: http://opendatacommons.org/licenses/odbl/1.0/
rights holder: IBIGroup
subject: SIO_000983
used data: disgenetv3.0rdf
authored by: http://orcid.org/0000-0001-5999-6269
authored by: http://orcid.org/0000-0002-7534-7661
authored by: 0000-0002-9383-528X
authored by: http://orcid.org/0000-0003-0169-8159
authored by: http://orcid.org/0000-0003-1244-7654
created by: http://orcid.org/0000-0003-0169-8159
version: v4.0.0.0

NP421630.RAt9eHzD-LlUhvh5xt3-ebBqBVdHOXdccOcIppHJSNQF0130 assertion
type: Assertion
description: [Treatment of human esophageal cancer KYSE 510 cells with 5-50 microM of EGCG for 12-144 h caused a concentration- and time-dependent reversal of hypermethylation of p16(INK4a), retinoic acid receptor beta (RARbeta), O(6)-methylguanine methyltransferase (MGMT), and human mutL homologue 1 (hMLH1) genes as determined by the appearance of the unmethylation-specific bands in PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
evidence: DisGeNET evidence - LITERATURE
SIO_000772: http://identifiers.org/pubmed/14633667
was generated by: ECO_0000203

befree-2016
imported on: 2016-02-19

DisGeNET evidence - LITERATURE
type: ECO_0000212
comment: Gene-disease associations inferred from text-mining the literature.

disgenetv3.0rdf
version: v4.0.0